Back to Journals » Drug Design, Development and Therapy » Volume 11

Spotlight on ceritinib in the treatment of ALK+ NSCLC: design, development and place in therapy

Total article views   Abstract views HTML views PDF downloads Totals
10,164 Dovepress* 7,259 1,489+ 949 8,748
PubMed Central* 0 1,416 401 1,416
Totals 7,259 2,905 1,350 10,164
*Since 5 July 2017
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
18 1 0 1 4 12

View citations on PubMed Central and Google Scholar